packageTralokinumab

tralokinumab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tralokinumab is a monoclonal antibody used to treat dermatitis (atopic skin inflammation). It is an approved medicine, though its use appears limited to dermatological care rather than broad application.

Summary written by glm-5.3-flash from Wikidata Q7833105 and the WHO ATC classification; not checked by a person.

name:tralokinumab
ATC codes:D11AH07
DrugBank:DB12169
Wikidata:Q7833105
molar mass:147000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown